REGINfo: Orion - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

OMXH 25 NEWS

FEEDS

My Google

Microsoft Live

My Yahoo

COMPANY SEARCH RESULT

$Orion: Click to view the issuer\'s details$

Last update : 03/04/2012 >View issuer details

2021.01.18 | 08:00 | Permanent Information Releases / General Company News

puce Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania - HTML (w)

2021.01.12 | 09:15 | Permanent Information Releases / Appointments

puce Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2021 AGM of Orion Corporation - HTML (w)

2020.12.18 | 08:10 | Permanent Information Releases / General Company News

puce 8,242 Orion Corporation A shares converted into B shares - HTML (w)

2020.11.10 | 07:30 | Permanent Information Releases / General Company News

puce Orion invests EUR 17 million in its production plants in Turku - HTML (w)

2020.10.29 | 18:00 | Permanent Information Releases / General Company News

puce Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion - HTML (w)

2020.10.21 | 17:40 | Permanent Information Releases / Appointments

puce Composition of the Nomination Committee of Orion Corporation - HTML (w)

2020.10.21 | 11:00 | Permanent Information Releases / General Company News

puce Orion Group Interim Report 1-9/2020 - HTML (w)

2020.10.19 | 19:35 | Permanent Information Releases / Sales and Revenues

puce Orion upgrades full-year outlook for 2020 - HTML (w)

2020.10.19 | 13:15 | Permanent Information Releases / General Company News

puce Orion's statutory co-operation negotiations completed regarding the Research & Development function - HTML (w)

2020.10.19 | 08:00 | Permanent Information Releases / General Company News

puce 120,939 Orion Corporation A shares converted into B shares - HTML (w)

2020.10.06 | 14:00 | Permanent Information Releases / General Company News

puce Orion publishes Interim Report for January-September 2020 on Wednesday 21 October 2020 - HTML (w)

2020.09.10 | 13:00 | Permanent Information Releases / General Company News

puce Orion is planning to renew its R&D strategy and organisation - HTML (w)

2020.09.10 | 06:30 | Permanent Information Releases / General Company News

puce New England Journal of Medicine publishes final overall survival data for darolutamide showing treatment significantly extends life in men with non-metastatic prostate cancer - HTML (w)

2020.07.31 | 14:30 | Permanent Information Releases / General Company News

puce Orion Corporation: Managers’ transactions – Jari Karlson - HTML (w)

2020.07.28 | 20:45 | Permanent Information Releases / General Company News

puce Orion’s phase 3 REFALS trial evaluating the efficacy of oral levosimendan in treatment of ALS patients did not reach its pre-specified endpoints - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 292